Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Sigmoidal Tumour × Morphine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pain 20 Neoplasms 19 Cancer Pain 16 Pain, Postoperative 12 Agnosia 8 Chronic Pain 7 Breast Neoplasms 5 Neoplasm Metastasis 4 Head and Neck Neoplasms 4 Colorectal Neoplasms 4 Colonic Neoplasms 4 Multiple Myeloma 3 Mucositis 3 Lymphoma, Follicular 3 Lymphoma 3 Lung Neoplasms 3 Leukemia, Myeloid, Acute 3 Leukemia, Biphenotypic, Acute 3 Leukemia 3 Wounds and Injuries 2 Waldenstrom Macroglobulinemia 2 Thrombocythemia, Essential 2 Supratentorial Neoplasms 2 Sezary Syndrome 2 Primary Myelofibrosis 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Precancerous Conditions 2 Polycythemia Vera 2 Pdgfra-Associated Chronic Eosinophilic Leukemia 2

Interventions

Morphine 1 Levobupivacaine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01825993 2013-04-08

2013/004

Corporacion Parc Tauli

Phase 3 Unknown

Sigmoidal Tumour

Data powered by HemOnc (CC BY 4.0) Colophon ⚡